The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

On Saturday, Gilead Sciences, Inc. (NASDAQ:GILD) and Merck & Co. Inc. (NYSE:MRK) revealed new results from a Phase 2 clinical ...

As groundbreaking studies continue to reshape the human immunodeficiency virus (HIV) landscape, emerging therapies and ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

Officials in Brazil’s well-regarded public health system are scrambling to explain this week how six transplant patients ...

The World Council of Churches has newly published a discussion document: Good News about HIV Treatment, Cure, and Healing: ...

In the complex landscape of chronic health conditions, living with HIV while recovering from a stroke presents a unique set ...

Indigenous communities in Latin America say they are being excluded from the global HIV/AIDS response, leaving them without ...

HIV activist Solly Nduku was recently elected to the top civil society position at the South African National Aids Council.

People with HIV are more likely to have severe premenstrual syndrome (PMS) symptoms than others, such as: In the United States, about 2% of transgender people make up new HIV diagnoses.

Among 198 patients with HIV who received a kidney from a deceased donor, risk of a safety event within a median of 2.2 years was similar between the two groups (adjusted HR 1.00, 95% CI 0.73-1.38), ...